Goldman Sachs Conviction List 2024. Published tue, mar 12 20247:21 pm edt. This is the updated conviction list as of february 2024, with their upside percentage projection:
Goldman sachs has removed merck (nyse:mrk) and vertex pharmaceuticals (nasdaq:vrtx) from its us conviction list, though it did add amgen. Goldman sachs just added — and removed — stocks on its ‘conviction list’ of top asian picks.
Apr 1, 2024 7:37 Pm Edt.
Goldman sachs has removed merck (nyse:mrk) and vertex pharmaceuticals (nasdaq:vrtx) from its us conviction list, though it did add amgen.
We Screened The List Looking For The Companies That Had The Largest Upside To The Goldman Sachs Assigned Target Prices, And We Found Five That Aggressive Investors.
The conviction buy list is.
We Decided To Screen The April Goldman Sachs U.s.
Images References :
Goldman Sachs Just Added — And Removed — Stocks On Its ‘Conviction List’ Of Top Asian Picks.
We decided to screen the april goldman sachs u.s.
This Is The Updated Conviction List As Of February 2024, With Their Upside Percentage Projection:
We screened the list looking for the companies that had the largest upside to the goldman sachs assigned target prices, and we found five that aggressive investors.
Goldman Sachs Has A Conviction Buy Rating And $109.00 Price Target On Its Shares.